LMR Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-33,824
| Closed | -$1.43M | – | 1041 |
|
|
2024
Q3 | $1.43M | Buy |
33,824
+23,743
| +236% | +$1.01M | 0.01% | 299 |
|
|
2024
Q2 | $406K | Sell |
10,081
-35,877
| -78% | -$1.45M | ﹤0.01% | 414 |
|
|
2024
Q1 | $1.63M | Buy |
45,958
+10,250
| +29% | +$363K | 0.02% | 253 |
|
|
2023
Q4 | $1.06M | Buy |
+35,708
| New | +$1.06M | 0.01% | 295 |
|
|
2023
Q2 | – | Sell |
-18,069
| Closed | -$734K | – | 1008 |
|
|
2023
Q1 | $734K | Buy |
+18,069
| New | +$734K | 0.01% | 637 |
|
|
2020
Q4 | – | Sell |
-28,801
| Closed | -$3.27M | – | 626 |
|
|
2020
Q3 | $3.27M | Sell |
28,801
-5,083
| -15% | -$577K | 0.07% | 108 |
|
|
2020
Q2 | $3.35M | Buy |
+33,884
| New | +$3.35M | 0.08% | 170 |
|
|
2018
Q4 | – | Sell |
-6,462
| Closed | -$277K | – | 479 |
|
|
2018
Q3 | $277K | Buy |
+6,462
| New | +$277K | 0.02% | 265 |
|
|
2017
Q3 | – | Sell |
-9,183
| Closed | -$74K | – | 540 |
|
|
2017
Q2 | $74K | Buy |
+9,183
| New | +$74K | ﹤0.01% | 576 |
|